Abstract
Hepatitis C virus (HCV) infects >10% of the general population in Egypt, in which intravenous injection with an antimony compound for endemic schistosomiasis in the past has been implicated. To simulate the epidemic history of HCV in Egypt, sera were obtained from 3608 blood donors at 13 governorates in or surrounding the Nile valley during 1999. The prevalence of antibody to HCV (anti-HCV) and genotypes was determined in them, and the molecular evolutionary analysis based on the neutral theory was applied to HCV isolates of genotype 4a, which is outstandingly prevalent in Egypt and indigenous there. Of 3608 sera, 317 (8.8%) were positive for anti-HCV. The molecular evolutionary analysis on 47 HCV genotype 4a isolates of carriers from various districts in Egypt indicated that the spread of HCV-4a would have increased exponentially during the 1940s through 1980 when oral medications became available. In conclusion, the estimated spread time is consistent with the duration of intravenous antimony campaigns in Egypt.
Similar content being viewed by others
References
MA Darwish TA Raouf P Rushdy NT Constantine MR Rao R Edelman (1993) ArticleTitleRisk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49 440–447 Occurrence Handle1:STN:280:ByuD38jlslU%3D Occurrence Handle7692754
G Dusheiko H Schmilovitz-Weiss D Brown F McOmish PL Yap S Sherlock N Mclntyre P Simmonds (1994) ArticleTitleHepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 19 13–18 Occurrence Handle1:STN:280:ByuC3c3mvVc%3D Occurrence Handle8276349
C Frank MK Mohamed GT Strickland D Lavanchy RR Arthur LS Magder T El Khoby Y Abdel-Wahab ES Aly Ohn W Anwar I Sallam (2000) ArticleTitleThe role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 887–891 Occurrence Handle10.1016/S0140-6736(99)06527-7 Occurrence Handle1:STN:280:DC%2BD3c3hsVekuw%3D%3D Occurrence Handle10752705
RG Hibbs AL Corwin NF Hassan M Kamel M Darwish R Edelman NT Constantine MR Rao AS Khalifa S Mokhtar (1993) ArticleTitleThe epidemiology of antibody to hepatitis C in Egypt. J Infect Dis 168 789–790 Occurrence Handle1:STN:280:ByyA2MbnvVU%3D Occurrence Handle8394867
MA Kamel YA Ghaffar MA Wasef M Wright LC Clark FD Miller (1992) ArticleTitleHigh HCV prevalence in Egyptian blood donors. Lancet 340 427 Occurrence Handle10.1016/0140-6736(92)91508-6 Occurrence Handle1:STN:280:By2A2cbotlY%3D
F McOmish PL Yap BC Dow EA Follett C Seed AJ Keller TJ Cobain T Krusius E Kolho R Naukkarinen (1994) ArticleTitleGeographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32 884–892 Occurrence Handle1:STN:280:ByuB1MbotFw%3D Occurrence Handle7913097
MA Nafeh A Medhat M Shehata NN Mikhail Y Swifee M Abdel-Hamid S Watts AD Fix GT Strickland W Anwar I Sallam (2000) ArticleTitleHepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 63 236–241 Occurrence Handle1:STN:280:DC%2BD3MzmtFWrsQ%3D%3D Occurrence Handle11421370
T Ohno M Mizokami RR Wu MG Saleh K Ohba E Orito M Mukaide R Williams JY Lau (1997) ArticleTitleNew hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35 201–207 Occurrence Handle1:CAS:528:DyaK2sXktVKksA%3D%3D Occurrence Handle8968908
OG Pybus A Rambaut (2002) ArticleTitleGENIE: Estimating demographic history from molecular phylogenies. Bioinformatics 18 1404–1405 Occurrence Handle10.1093/bioinformatics/18.10.1404 Occurrence Handle1:CAS:528:DC%2BD38XnvF2ru7o%3D Occurrence Handle12376389
OG Pybus A Rambaut PH Harvey (2000) ArticleTitleAn integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155 1429–1437 Occurrence Handle1:STN:280:DC%2BD3cvgsVSnuw%3D%3D Occurrence Handle10880500
OG Pybus MA Charleston S Gupta A Rambaut EC Holmes PH Harvey (2001) ArticleTitleThe epidemic behavior of the hepatitis C virus. Science 292 2323–2325 Occurrence Handle10.1126/science.1058321 Occurrence Handle1:CAS:528:DC%2BD3MXkslSht78%3D Occurrence Handle11423661
OG Pybus AJ Drummond T Nakano BH Robertson A Rambaut (2003) ArticleTitleThe epidemiology and iatrogenic transmission of hepatitis C virus in egypt: a bayesian coalescent approach. Mol Biol Evol 20 381–387 Occurrence Handle10.1093/molbev/msg043 Occurrence Handle1:CAS:528:DC%2BD3sXisFaqs7s%3D Occurrence Handle12644558
MR Rao AB Naficy E Schisterman JD Clemens R Edelman MA Darwish NM Darwish (2002) ArticleTitleFurther evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis 2 29 Occurrence Handle10.1186/1471-2334-2-29 Occurrence Handle1:CAS:528:DC%2BD38Xptlaqtr0%3D Occurrence Handle12464161
SC Ray RR Arthur A Carella J Bukh DL Thomas (2000) ArticleTitleGenetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis 182 698–707 Occurrence Handle10.1086/315786 Occurrence Handle1:CAS:528:DC%2BD3cXmvVCjt74%3D Occurrence Handle10950762
MP Stumpf OG Pybus (2002) ArticleTitleGenetic diversity and models of viral evolution for the hepatitis C virus. FEMS Microbiol Lett 214 143–152 Occurrence Handle10.1016/S0378-1097(02)00854-6 Occurrence Handle1:CAS:528:DC%2BD38Xnt1Kmtb4%3D Occurrence Handle12351222
T Takeuchi A Katsume T Tanaka A Abe K Inoue K Tsukiyama-Kohara R Kawaguchi S Tanaka M Kohara (1999) ArticleTitleReal-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116 636–642 Occurrence Handle1:CAS:528:DyaK1MXhvVOntL4%3D Occurrence Handle10029622
Y Tanaka K Hanada M Mizokami AE Yeo JW Shih T Gojobori HJ Alter (2002) ArticleTitleInaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 99 15584–15589 Occurrence Handle10.1073/pnas.242608099 Occurrence Handle1:CAS:528:DC%2BD3sXjvVyl Occurrence Handle12438687
InstitutionalAuthorNameWHO (1993) The control of schistosomiasis: Second report of the WHO expert committee (WHO Technical Report Series 830). WHO Geneva
Acknowledgements
This study was supported by grants-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Science, and Sports of Japan (14770239), a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan (H13-kanen-2), and the Public Trust Haraguchi Memorial Cancer Research Fund. We greatly appreciate Dr. Oliver G. Pybus (Department of Zoology, University of Oxford, Oxford, UK) for his enlightening advice on the molecular evolutionary analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, Y., Agha, S., Saudy, N. et al. Exponential Spread of Hepatitis C Virus Genotype 4a in Egypt . J Mol Evol 58, 191–195 (2004). https://doi.org/10.1007/s00239-003-2541-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00239-003-2541-3